PPARG and colonic neoplasm: In contrast, a study by Lefebvre et al. showed that PPARγ ligands, including troglitazone and BRL-49653, promoted colon tumor development in C57BL/6JAPCMin/+ mice, raising the possibility that PPARγ acts as a collaborative oncogene in certain circumstances [34].